Indications and practice with androgen deprivation therapy.
Publication
, Journal Article
Moul, JW; Kibel, AS; Roach, M; Dreicer, R
Published in: Urology
November 2011
The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is an ongoing longitudinal observational study of current trends in prostate cancer staging and treatment across a spectrum of different treatment facilities in the United States. To date, the study has documented 2 principal findings: (a) a large variation exists in the treatment choices applied to similar patient presentations across the range of facility type, size, and geographic location in the United States; and (b) although it does not seem to make much difference in mortality outcomes which approach--hormonal therapy, radiotherapy, or surgery--is applied to men at low or intermediate risk, a survival benefit exists with surgery for men at high risk.
Duke Scholars
Published In
Urology
DOI
EISSN
1527-9995
Publication Date
November 2011
Volume
78
Issue
5 Suppl
Start / End Page
S478 / S481
Location
United States
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Male
- Humans
- Androgen Antagonists
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Kibel, A. S., Roach, M., & Dreicer, R. (2011). Indications and practice with androgen deprivation therapy. Urology, 78(5 Suppl), S478–S481. https://doi.org/10.1016/j.urology.2011.04.025
Moul, Judd W., Adam S. Kibel, Mack Roach, and Robert Dreicer. “Indications and practice with androgen deprivation therapy.” Urology 78, no. 5 Suppl (November 2011): S478–81. https://doi.org/10.1016/j.urology.2011.04.025.
Moul JW, Kibel AS, Roach M, Dreicer R. Indications and practice with androgen deprivation therapy. Urology. 2011 Nov;78(5 Suppl):S478–81.
Moul, Judd W., et al. “Indications and practice with androgen deprivation therapy.” Urology, vol. 78, no. 5 Suppl, Nov. 2011, pp. S478–81. Pubmed, doi:10.1016/j.urology.2011.04.025.
Moul JW, Kibel AS, Roach M, Dreicer R. Indications and practice with androgen deprivation therapy. Urology. 2011 Nov;78(5 Suppl):S478–S481.
Published In
Urology
DOI
EISSN
1527-9995
Publication Date
November 2011
Volume
78
Issue
5 Suppl
Start / End Page
S478 / S481
Location
United States
Related Subject Headings
- Urology & Nephrology
- Prostatic Neoplasms
- Male
- Humans
- Androgen Antagonists
- 3202 Clinical sciences
- 1103 Clinical Sciences